In patients with advanced NSCLC, high BAP1 expression was found to be associated with a lack of lymph node metastasis and a longer median survival time [6], and deletions in the BAP1 gene were present in lung adenocarcinoma and other types of human cancers [7]. This evidence concerns the gene BAP1 and lung adenocarcinoma.